Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-30, Stock:JNJ, The news for the past five days is as follows:
2019-07-23: NEWS1: How to Invest in Cancer-Fighting Stocks.NEWS2: Biogen (BIIB) Up on Q2 Earnings & Sales Beat, Raised View.NEWS3: Biogen (BIIB) Up on Q2 Earnings & Sales Beat, Raised View.NEWS4: Here's Why the Best Is Yet to Come for UroGen Pharma.NEWS5: Here's Why the Best Is Yet to Come for UroGen Pharma.NEWS6: SPLG, JNJ, T, WMT: ETF Inflow Alert.NEWS7: SPLG, JNJ, T, WMT: ETF Inflow Alert.NEWS8: Biogen (BIIB) Up on Q2 Earnings & Sales Beat, Raised View.NEWS9: Will Humira & Other Drugs Drive AbbVie's (ABBV) Q2 Earnings?.NEWS10: Will Humira & Other Drugs Drive AbbVie's (ABBV) Q2 Earnings?.NEWS11: Health Care Sector Update for 07/23/2019: JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 07/23/2019: JNJ, PFE, ABT, MRK, AMGN.NEWS13: Will Humira & Other Drugs Drive AbbVie's (ABBV) Q2 Earnings?.NEWS14: 3 of the Most Rock-Solid Dividend Stocks in the World.NEWS15: 3 of the Most Rock-Solid Dividend Stocks in the World.NEWS16: 3 of the Most Rock-Solid Dividend Stocks in the World.NEWS17: The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Merck, Johnson & Johnson and IBM.NEWS18: The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Merck, Johnson & Johnson and IBM.NEWS19: Drugmakers shell out record amount lobbying Congress.
2019-07-24: NEWS1: Is Johnson & Johnson Stock Losing Its Shine?.NEWS2: Health Care Sector Update for 07/24/2019: ANTM, SGEN, TMO, JNJ, PFE, ABT, MRK, AMGN.NEWS3: Health Care Sector Update for 07/24/2019: ANTM, SGEN, TMO, JNJ, PFE, ABT, MRK, AMGN.NEWS4: JNJ Named Top 25 SAFE Dividend Stock Increasing Payments For Decades.NEWS5: JNJ Named Top 25 SAFE Dividend Stock Increasing Payments For Decades.
2019-07-25: NEWS1: Glaxo (GSK) Beats on Q2 Earnings, Shingrix Sales Strong.NEWS2: Glaxo (GSK) Beats on Q2 Earnings, Shingrix Sales Strong.NEWS3: Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now.NEWS4: Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now.NEWS5: UPDATE 2-Deployment of second Ebola vaccine would not be quick fix, experts warn.NEWS6: Glaxo (GSK) Beats on Q2 Earnings, Shingrix Sales Strong.NEWS7: Health Care Sector Update for 07/25/2019: GEMP, QGEN, AZN, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 07/25/2019: GEMP, QGEN, AZN, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now.NEWS10: What Are Analysts Saying About The Future Of Johnson & Johnson's (NYSE:JNJ)?.
2019-07-26: NEWS1: AbbVie (ABBV) Beats on Q2 Earnings & Sales, Raises EPS View.NEWS2: AbbVie (ABBV) Beats on Q2 Earnings & Sales, Raises EPS View.NEWS3: AbbVie (ABBV) Beats on Q2 Earnings & Sales, Raises EPS View.NEWS4: Senate advances bill to cut the cost of prescriptions.NEWS5: Health Care Sector Update for 07/26/2019: EHTH, CUR, VSTM, SNY, JNJ, PFE, ABT, MRK, AMGN.NEWS6: Health Care Sector Update for 07/26/2019: EHTH, CUR, VSTM, SNY, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Is the Colombian Cannabis Industry Leading Latin America, Or Just Leading Investors On A Wild Goose Chase?.NEWS8: The Daily Biotech Pulse: Obseva Gets The Greenlight, Verastem Climbs On Licensing Deal, Merit Medical Earnings Disappoint.NEWS9: Drugmakers: Our Take on Earnings.
2019-07-29: NEWS1: US Indexes Close Mostly Lower on Monday.NEWS2: Dow Outperforms Ahead of Busy Week on Wall Street.NEWS3: Dow Outperforms Ahead of Busy Week on Wall Street.NEWS4: UPDATE 2-J&J says FTC probing efforts to protect arthritis drug Remicade.NEWS5: J&J says FTC probing efforts to protect arthritis drug Remicade.NEWS6: J&J says FTC probing efforts to protect arthritis drug Remicade.NEWS7: J&J says FTC probing efforts to protect arthritis drug Remicade.NEWS8: 5 Top Stock Trades for Tuesday: SHOP, NFLX, JNJ.NEWS9: Dow Jones Edges Higher on Monday.NEWS10: Pfizer to Combine Off-Patent Drug Business With Mylan.NEWS11: 3 Healthcare Stocks With Rising Expectations.NEWS12: 3 Healthcare Stocks With Rising Expectations.NEWS13: 3 Healthcare Stocks With Rising Expectations.NEWS14: Why Johnson & Johnson Stock Isn’t a Buy… Yet.

Answer: Decrease